Our company's annual report for 2024 has been published.

Throughout 2024, CranioCatch reached significant milestones both nationally and internationally. The company ranked among the top five in the APS Project Acceleration Program supported by the European Union and the Republic of Türkiye Ministry of Industry and Technology, earning the right to join the overseas program under export support. It successfully completed ISO 27001, ISO/IEC 15504 SPICE Level-2, and ISO 12207 certification processes. In addition, under TÜBİTAK’s 1501 Industrial R&D Projects Support Program, its project titled 'AI-Assisted Ultrasonographic Diagnosis and Reporting System' became eligible for funding. In line with its growth targets in international markets, the company signed a distribution agreement in Greece with a firm named Custom Bone and initiated efforts to establish a wholly owned subsidiary in the United States. As part of AI-focused innovations in dentistry, it integrated its AI-powered technology into the Dr. Dentes platform. Through the web-based online system, once patient radiographs are uploaded, analysis and reporting can be performed within seconds via the AI analysis button. CranioCatch also contributed to organizing the world’s first AI in dentistry hackathon. The company won first place in the Digital Angel Investment program organized by Webtures, receiving 300,000 TRY in digital marketing service investment support. To strengthen its presence in the entrepreneurship ecosystem, it participated in major events such as the Take Off Startup Summit, creating opportunities for collaboration and knowledge sharing with stakeholders. Our CEO, Assoc. Prof. İbrahim Şevki Bayrakdar, delivered notable talks on AI solutions in dentistry at Recep Tayyip Erdoğan University and Cappadocia University.